Exact peptide identities attached to retained registry observations carrying this condition label.
Official registry condition
Non-alcoholic Fatty Liver Disease peptide trials
3 selected ClinicalTrials.gov records carrying the official condition label Non-alcoholic Fatty Liver Disease. The label is copied from each retained registry version and does not imply that PeptideScanner has verified a diagnosis, treatment relationship, or study result.
3 selected records.
2 profiles.
2021–2026 in selected records.
Indication intelligence
Selected evidence landscape
Phase labels copied from the retained ClinicalTrials.gov versions.
Overall statuses at each retained observation, not necessarily current today.
Across the connected peptide profiles, PeptideScanner also carries 109 selected PubMed records and 5 selected Drugs@FDA applications. Those records are profile context only; PeptideScanner does not claim they concern Non-alcoholic Fatty Liver Disease unless their own cited source says so.
Collection change ledger
Recently changed records on this condition hub
These events come only from the exact registry records shown on this page. The condition label does not establish a diagnosis, treatment relationship, or scientific agreement.
ClinicalTrials.gov record NCT06465186
PeptideScanner retained ClinicalTrials.gov record NCT06465186 at 2026-11-16T17:46:45.897Z. Its registry update date was 2026-09-21, and PeptideScanner's reviewed identity mapping was efinopegdutide.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- September 21, 2026
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT06482112
PeptideScanner retained ClinicalTrials.gov record NCT06482112 at 2026-11-16T17:46:45.897Z. Its registry update date was 2026-06-01, and PeptideScanner's reviewed identity mapping was efinopegdutide.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- June 1, 2026
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT03357380
PeptideScanner retained ClinicalTrials.gov record NCT03357380 at 2026-07-30T19:56:31.568Z. Its registry update date was 2021-11-22, and PeptideScanner's reviewed identity mapping was semaglutide.
- PeptideScanner change date
- August 13, 2026
- Cited source date
- November 22, 2021
- Evidence lane
- Clinical trials
Attributed registry records
Selected records
Efinopegdutide · 2026-09-21
ClinicalTrials.gov record NCT06465186
Completed at the retained observation.
Open attributed record →Efinopegdutide · 2026-06-01
ClinicalTrials.gov record NCT06482112
Completed at the retained observation.
Open attributed record →Semaglutide · 2021-11-22
ClinicalTrials.gov record NCT03357380
Completed at the retained observation.
Open attributed record →